Clinical Trials Browser

Phase 2 × Injections × Breast × Clear all

NCT06198751 2025-08-19

A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms

NCT06172127 2025-07-29

DEMETHER

Phase 2 Recruiting

Breast Neoplasms

NCT06199895 2025-06-03

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Phase 2 Recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT06957379 2025-05-04

Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy

Phase 2 Active not recruiting

Breast Neoplasms

NCT05332561 2025-03-20

Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)

Phase 2 Recruiting

Breast Neoplasms

NCT06452706 2024-11-19

The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT05911958 2024-11-04

A Study of SHR-A1811 as Neoadjuvant Treatment for Patients With HR-Positive, Low HER2 Expression Breast Cancer

Phase 2 Recruiting

HER2 Low Breast Carcinoma

NCT06389006 2024-05-23

To Evaluate the Efficacy and Safety of Disitamab Vedotin Combined With Toripalimab Sequential Chemotherapy as Neoadjuvant Treatment in Patients With HR-positive, HER2-low Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

Breast Neoplasms

NCT03139851 2021-09-10

CHEMOIMMUNE

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT03024580 2019-08-15

MEGA

Phase 2 Unknown

Breast Neoplasms

NCT03203616 2018-11-29

KIARA

Phase 2 Withdrawn

Metastatic HER2-positive Breast Cancer With Brain Metastasis

NCT02953184 2017-12-29

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Phase 2 Unknown

Breast Neoplasms

NCT00918281 2014-06-09

Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection

Phase 2 Completed

70 enrolled 9 charts

BreastGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Head and Neck Neoplasms, Lung Neoplasms, Sarcoma

NCT01428414 2012-08-23

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00955890 2012-02-28

cardioprotec

Phase 2 Terminated

Breast Neoplasms